Press Releases

Featured Press Releases

BIO Statement on December 2025 ACIP Meeting

WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…

Learn more

BIO Statement on the Retirement of Richard Pazdur…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…

Learn more

BIO Statement on House Passage of Mikaela Naylon…

WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…

Learn more

Call for Sessions for BIO's Impact Ag & Environment Conference

April 27, 2023

BIO’s Impact Ag & Environment Conference, Sept. 19-20, 2023, in Raleigh, N.C., is an opportunity for companies and non-governmental organizations working across agriculture, bioprocessing, and climate adaptation/mitigation to connect and…

BIO to redouble efforts to ensure regulatory decision-making is "grounded in scientific and medical expertise"

April 21, 2023

The Supreme Court ruled today that mifepristone will remain accessible during the appeals process of the April 7 Texas ruling that would have declared the Food and Drug Administration (FDA) approval of the drug invalid. BIO interim…

BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS

April 11, 2023

BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS AND CURES TO PATIENTS “We will continue to organize and mobilize America’s scientific community to challenge this unprecedented effort to undermine…

New ruling out of Texas sets "dangerous precedent for undermining the FDA"

April 8, 2023

A federal judge in Texas rules this week to suspend the FDA’s approval of mifepristone. BIO interim President and CEO, Rachel King, released the following statement: “The preliminary ruling by a federal judge in Texas is an assault on science…

Majority of American Voters Want Congress to Prioritize and Fund Public Health Preparedness, Poll Reveals

March 30, 2023

Healthcare Ready, Biotechnology Innovation Organization, and Wakefield Research release data Washington (March 30, 2023) -- The last several years have shown that preparing for a public health emergency is vital to protect the public, our…

Innovation & Jobs Act Needed to Spur Innovation and Strengthen America's Global Competitiveness

March 17, 2023

Biotechnology companies are hard at work on the cutting-edge innovations we need, but those breakthroughs are at risk from current tax policy. The Biotechnology Innovation Organization, which represents more than 1,000 biotech companies, thanks…

BIO Welcomes John Delacourt as Deputy General Counsel

March 15, 2023

Mr. Delacourt is a senior litigator and regulatory counselor with more than a decade of experience advising biotech companies WASHINGTON – (March 15, 2023) – The Biotechnology Innovation Organization (BIO) welcomes John Delacourt as Deputy General…

Silicon Valley Bank and Biotech

March 13, 2023

"The ecosystem that allows America to develop groundbreaking new medicines is extremely important to our nation and to patients who depend on biotechnology companies. The recent actions by the FDIC, the Federal Reserve, and Treasury to allow SVB…

White House Budget Proposal a "Costly Blow" to Patients, Innovation

March 9, 2023

President Biden today unveiled details of the White House’s budget request that included drastic changes to the Medicare program, including further expanding the program’s new authority to institute price controls in Medicare. BIO Chief Advocacy…

Ag & Bioscience Groups: It's Time for Action on Mexico's Biotech Corn Ban

March 9, 2023

A broad coalition of national and state agriculture and bioscience organizations have written President Biden to thank the administration for beginning technical consultations with Mexico concerning its action to ban imports of biotech corn. The…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.